The HOPE study was the first to explore that ACE inhibitor ramipril prevents the development of diabetes.[11] The possibility that reduce the number of new cases of diabetes was also supported by a number of other studies.[32–36] As monotherapy, two trials have evaluated the use of ramipril in diabetic patients [Table 5]. Here, ACE is linked to diabetes mellitus.